Ghulam Jilany Khan

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 3

Top Topics

Antiplatelet Therapy

Pulmonary Embolism

Breast Cancer Cells

Top Venues

Endocrine, metabolic & immune disorders drug targets

International journal of molecular sciences

Molecules (Basel, Switzerland)

University of Central Punjab

China Pharmaceutical University, National Drug Screening Center, Jiangsu Center of Key Research. (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Central Punjab

Pakistan

Associate Prof. :: Department of Pharmacology and Therapeutics, Faculty of Pharmacy

Education History

China Pharmaceutical University, National Drug Screening Center, Jiangsu Center of Key Research.

China

PHD :: Department of Pharmacology and Oncology and Pharmacodynamic Research.

Publications

Ghulam Jilany Khan, Abeeha Imtiaz, Wei Wang, Hong Duan, Hui Cao, Kefeng Zhai, Nongyue He
Thymus as Incontrovertible Target of Future Immune Modulatory Therapeutics. Endocrine, metabolic & immune disorders drug targets (2024)
Gamariel Rwibasira Rudinga, Ghulam Jilany Khan, Yi Kong
Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy. International journal of molecular sciences 19 (2) (2018)
Chu Thi Thanh Huyen, Nguyen Phuong Thao, Ghulam Jilany Khan, Ha Van Oanh, Ta Manh Hung, Hui-Jun Li, Ping Li
Chemical Constituents from Cimicifuga dahurica and Their Anti-Proliferative Effects on MCF-7 Breast Cancer Cells. Molecules (Basel, Switzerland) 23 (5) (2018)